EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy

Carissa A Low iD, Christianna Bartel iD, Krina Durica iD, Heidi S Donovan iD, Roby Thomas iD, Jennifer Fedor iD

JCO Clinical Cancer Informatics · 2025

DOI: 10.1200/cci-25-00111 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JCO Clinical Cancer Informatics, 2025. Verfasst von Carissa A Low und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh, Pittsburgh, PA. Hauptthemen laut MEDLINE: Wearable Electronic Devices, Gait, Neoplasms, Exercise. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Consumer wearable devices provide new opportunities for measuring patterns of objective daily physical activity throughout cancer treatment. In addition to capturing step counts, these devices can also measure gait cadence and activity fragmentation, two metrics that may reflect functional capacity. The goal of the current study was to examine whether step count, gait cadence, and activity fragmentation predicted overall survival in patients with solid tumors. METHODS We enrolled patients (N = 213) receiving outpatient chemotherapy for any solid tumor into an observational cohort study. Patients wore a consumer wearable device to measure continuous physical activity patterns for up to 90 days and were followed for a median of 2.53 years, during which 42% of the sample died. Univariable and multivariable Cox proportional hazards regression analyses were used to evaluate associations between wearable device physical function metrics and survival. RESULTS In univariable analyses, higher step count (hazard ratio (HR), 0.87; P = .007), less activity fragmentation (HR, 1.03; P < .001), and faster peak gait cadence (HR, 0.81; P < .001) were significantly associated with lower mortality risk. Associations with activity fragmentation and gait cadence persisted after adjustment for age and cancer type and stage and after additional adjustment for clinician-rated performance status and patient-reported physical function. CONCLUSION Activity fragmentation and gait cadence metrics derived from consumer wearable devices were associated with overall survival in patients receiving chemotherapy for any solid tumor. These associations remained statistically significant after adjustment for covariates, including clinician-rated performance status and patient-reported physical function. These findings suggest that wearable devices may capture important prognostic information about physical function independent of what clinicians and patients perceive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wearable Electronic DevicesGaitNeoplasmsExerciseHumansFemaleMaleMiddle AgedAgedPrognosisAdult

Autor:innen und Institutionen

  • University of Pittsburgh, Pittsburgh, PA.
  • University of Pittsburgh Medical Center, Pittsburgh, PA.

ORCID-Profile: Carissa A Low, Christianna Bartel, Krina Durica, Heidi S Donovan, Roby Thomas, Jennifer Fedor

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Low, C. A., Bartel, C., Durica, K., Donovan, H. S., Thomas, R., & Fedor, J. (2025). Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-25-00111

Vancouver

Low CA, Bartel C, Durica K, Donovan HS, Thomas R, Fedor J. Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-25-00111

BibTeX
@article{Low2025,
  author = {Low, Carissa A and Bartel, Christianna and Durica, Krina and Donovan, Heidi S and Thomas, Roby and Fedor, Jennifer},
  title = {Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy},
  journal = {JCO Clinical Cancer Informatics},
  year = {2025},
  doi = {10.1200/cci-25-00111}
}
Kostenlos starten →